ergonovine and mibefradil

ergonovine has been researched along with mibefradil in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dantzig, AH; Ekins, S; Kim, RB; Lan, LB; Leake, BF; Schuetz, EG; Schuetz, JD; Shepard, RL; Wikel, JH; Winter, MA; Wrighton, SA; Yasuda, K1
Berdeaux, A; Dubois-Randé, JL; Giudicelli, JF; Karila-Cohen, D1

Other Studies

2 other study(ies) available for ergonovine and mibefradil

ArticleYear
Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein.
    Molecular pharmacology, 2002, Volume: 61, Issue:5

    Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Ergonovine; Fluoxetine; Humans; Models, Molecular; Oxytocics; Protein Conformation; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship; Swine; Transfection; Vinblastine

2002
Effects of mibefradil on large and small coronary arteries in conscious dogs: role of vascular endothelium.
    Journal of cardiovascular pharmacology, 1996, Volume: 28, Issue:2

    Topics: Animals; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Coronary Vessels; Dogs; Endothelium, Vascular; Ergonovine; Heart Rate; In Vitro Techniques; Mibefradil; Tetrahydronaphthalenes; Vasodilation; Vasodilator Agents

1996